MYD88 and neoplasm: Mechanistically, in chimeric and conditionally targeted PDAC mouse models, myeloid-specific TLR4 signaling executes the MyD88-independent TRIF pathway to promote tumor growth, whereas MyD88-dependent signaling inhibits tumor growth [19].